B Cell Overview | Thermo Fisher Scientific - US
Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells | The EMBO Journal
A Guide to Breg Markers | Biocompare: The Buyer's Guide for Life Scientists
Unraveling B cell trajectories at single cell resolution: Trends in Immunology
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
Standing out from the crowd: How to identify plasma cells
CD antigens expression in B cells | Sino Biological
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
Antigen-experienced CXCR5- CD19low B cells are plasmablast precursors expanded in SLE | medRxiv
Frontiers | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases | SpringerLink
A new staining protocol for detection of murine antibody‐secreting plasma cell subsets by flow cytometry - Pracht - 2017 - European Journal of Immunology - Wiley Online Library
Cells | Free Full-Text | Altered Phenotype and Enhanced Antibody-Producing Ability of Peripheral B Cells in Mice with Cd19-Driven Cre Expression
CD19-The Most Popular Target with CAR T-Cell Therapy-CUSABIO
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Introduction to Flow Cytometric Analysis | Flow Cytometry
Identification of dual positive CD19+/CD3+ T cells in a leukapheresis product undergoing CAR transduction: a case report | Journal for ImmunoTherapy of Cancer
CD19 - The Marker, the Antibodies | Bio-Rad
Modulation of CD19 promoter activity in cHL and B-NHL cell lines. (A)... | Download Scientific Diagram
Modulation of CD19 surface expression in B cell acute lymphoblastic leukemia | Nature Immunology
CD antigens expression in B cells | Sino Biological
Cancers | Free Full-Text | CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1− Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells
What Is CD19 Antigen? – Creative Biolabs CAR-T Blog
B Cell Overview | Thermo Fisher Scientific - US
T Cell Markers and B Cell Markers
Frontiers | Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
B Cell Overview | Thermo Fisher Scientific - US
